Ergoteles LLC Oric Pharmaceuticals, Inc. Transaction History

Ergoteles LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.41 - $5.89 $99,561 - $243,327	-41,312 Reduced 49.28%	42,523 $250,000
Q3 2022 Nov 14, 2022	SELL	$3.15 - $5.24 $218,184 - $362,948	-69,265 Reduced 45.24%	83,835 $268,000
Q2 2022 Aug 12, 2022	BUY	$2.7 - $7.07 $413,370 - $1.08 Million	153,100 New	153,100 $686,000

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.